Most BRCA1-deficient breast cancers carry a dysfunctional INK4-CDK4/6-RB pathway 13, 40, 41, All widely used BRCA1 mutant breast cancer cell lines have deletions in either RB or p16 42, 43. This evidence concerns the gene CDK4 and breast carcinoma.